Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 552

    1.

    Clinical predictors of prolonged delay in return of the international normalized ratio to within the therapeutic range after excessive anticoagulation with warfarin.

    Hylek EM, Regan S, Go AS, Hughes RA, Singer DE, Skates SJ.

    Ann Intern Med. 2001 Sep 18;135(6):393-400.PMID: 11560452 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Summaries for patients. Predicting risk for prolonged high INR after too much anticoagulation.

    [No authors listed]

    Ann Intern Med. 2001 Sep 18;135(6):I-37. No abstract available. PMID: 11575277 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Acetaminophen and other risk factors for excessive warfarin anticoagulation.

    Hylek EM, Heiman H, Skates SJ, Sheehan MA, Singer DE.

    JAMA. 1998 Mar 4;279(9):657-62.PMID: 9496982 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Prospective study of the outcomes of ambulatory patients with excessive warfarin anticoagulation.

    Hylek EM, Chang YC, Skates SJ, Hughes RA, Singer DE.

    Arch Intern Med. 2000 Jun 12;160(11):1612-7.PMID: 10847254 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Effectiveness and safety of a management protocol to correct over-anticoagulation with oral vitamin K: a retrospective study of 1,043 cases.

    Denas G, Marzot F, Offelli P, Stendardo A, Cucchini U, Russo R, Nante G, Iliceto S, Pengo V.

    J Thromb Thrombolysis. 2009 Apr;27(3):340-7. Epub 2008 Mar 13.PMID: 18338109 [PubMed - indexed for MEDLINE]Related articles

    6.

    Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.

    Fang MC, Chang Y, Hylek EM, Rosand J, Greenberg SM, Go AS, Singer DE.

    Ann Intern Med. 2004 Nov 16;141(10):745-52.PMID: 15545674 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Warfarin dose reduction vs watchful waiting for mild elevations in the international normalized ratio.

    Banet GA, Waterman AD, Milligan PE, Gatchel SK, Gage BF.

    Chest. 2003 Feb;123(2):499-503.PMID: 12576372 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

    Ansell J, Hirsh J, Poller L, Bussey H, Jacobson A, Hylek E.

    Chest. 2004 Sep;126(3 Suppl):204S-233S. Erratum in: Chest. 2005 Jan;127(1):415-6. Dosage error in article text. PMID: 15383473 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    A retrospective evaluation of vitamin K1 therapy to reverse the anticoagulant effect of warfarin.

    Fan J, Armitstead JA, Adams AG, Davis GA.

    Pharmacotherapy. 2003 Oct;23(10):1245-50.PMID: 14594342 [PubMed - indexed for MEDLINE]Related articles

    10.

    The risk of hemorrhage among patients with warfarin-associated coagulopathy.

    Garcia DA, Regan S, Crowther M, Hylek EM.

    J Am Coll Cardiol. 2006 Feb 21;47(4):804-8. Epub 2006 Jan 26.PMID: 16487849 [PubMed - indexed for MEDLINE]Related articles

    11.

    Treatment of excessive anticoagulation with phytonadione (vitamin K): a meta-analysis.

    Dezee KJ, Shimeall WT, Douglas KM, Shumway NM, O'malley PG.

    Arch Intern Med. 2006 Feb 27;166(4):391-7.PMID: 16505257 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    A feasibility study of continuing dose-reduced warfarin for invasive procedures in patients with high thromboembolic risk.

    Larson BJ, Zumberg MS, Kitchens CS.

    Chest. 2005 Mar;127(3):922-7.PMID: 15764777 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Oral vitamin K lowers the international normalized ratio more rapidly than subcutaneous vitamin K in the treatment of warfarin-associated coagulopathy. A randomized, controlled trial.

    Crowther MA, Douketis JD, Schnurr T, Steidl L, Mera V, Ultori C, Venco A, Ageno W.

    Ann Intern Med. 2002 Aug 20;137(4):251-4.PMID: 12186515 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Temporary discontinuation of warfarin therapy: changes in the international normalized ratio.

    White RH, McKittrick T, Hutchinson R, Twitchell J.

    Ann Intern Med. 1995 Jan 1;122(1):40-2.PMID: 7985894 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Falsely elevated international normalized ratio values in patients undergoing anticoagulation therapy: a descriptive evaluation.

    Delate T, Witt DM, Jones JR, Bhardwaja B, Senser M.

    Chest. 2007 Mar;131(3):816-22.PMID: 17356098 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Risk of warfarin-related bleeding events and supratherapeutic international normalized ratios associated with complementary and alternative medicine: a longitudinal analysis.

    Shalansky S, Lynd L, Richardson K, Ingaszewski A, Kerr C.

    Pharmacotherapy. 2007 Sep;27(9):1237-47.PMID: 17723077 [PubMed - indexed for MEDLINE]Related articles

    17.

    The use of vitamin K in patients on anticoagulant therapy: a practical guide.

    Hanslik T, Prinseau J.

    Am J Cardiovasc Drugs. 2004;4(1):43-55. Review.PMID: 14967065 [PubMed - indexed for MEDLINE]Related articles

    18.

    The necessity to assess anticoagulation status in elderly injured patients.

    Williams TM, Sadjadi J, Harken AH, Victorino GP.

    J Trauma. 2008 Oct;65(4):772-6; discussion 776-7.PMID: 18849789 [PubMed - indexed for MEDLINE]Related articles

    19.

    Oral vitamin K versus placebo to correct excessive anticoagulation in patients receiving warfarin: a randomized trial.

    Crowther MA, Ageno W, Garcia D, Wang L, Witt DM, Clark NP, Blostein MD, Kahn SR, Vesely SK, Schulman S, Kovacs MJ, Rodger MA, Wells P, Anderson D, Ginsberg J, Selby R, Siragusa S, Silingardi M, Dowd MB, Kearon C.

    Ann Intern Med. 2009 Mar 3;150(5):293-300.PMID: 19258557 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Risk factors for bleeding during anticoagulation of atrial fibrillation in older and younger patients in clinical practice.

    Abdelhafiz AH, Wheeldon NM.

    Am J Geriatr Pharmacother. 2008 Mar;6(1):1-11.PMID: 18396243 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data